Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-08

Clinical Trial Update: Tranexamic Acid Versus Blood Stopper Treatments in Epistaxis Management [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing tranexamic acid with Blood Stopper Treatments for epistaxis management is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Blood Stopper Treatments
  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Ankara Ataturk Sanatorium Training and Research Hospital | Conditions: Epistaxis Nosebleed | Phase 4 | Status: NOT_YET_RECRUITING